Literature DB >> 22895073

Preferential induction of apoptotic cell death in melanoma cells as compared with normal keratinocytes using a non-thermal plasma torch.

Shoshanna N Zucker1, Jennifer Zirnheld, Archis Bagati, Thomas M DiSanto, Benjamin Des Soye, Joseph A Wawrzyniak, Kasra Etemadi, Mikhail Nikiforov, Ronald Berezney.   

Abstract

Selective induction of apoptosis in melanoma cells is optimal for therapeutic development. To achieve this goal, a non-thermal helium plasma torch was modified for use on cultured cells in a temperature-controlled environment. Melanoma cells were targeted with this torch (1) in parallel cultures with keratinocytes, (2) in co-culture with keratinocytes and (3) in a soft agar matrix. Melanoma cells displayed high sensitivity to reactive oxygen species generated by the torch and showed a 6-fold increase in cell death compared with keratinocytes. The extent of cell death was compared between melanoma cells and normal human keratinocytes in both short-term (5 min) co-culture experiments and longer assessments of apoptotic cell death (18-24 h). Following a 10 sec plasma exposure there was a 4.9-fold increase in the cell death of melanoma vs. keratinocytes as measured after 24 h at the target site of the plasma beam. When the treatment time was increased to 30 sec, a 98% cell death was reported for melanoma cells, which was 6-fold greater than the extent of cell death in keratinocytes. Our observations further indicate that this preferential cell death is largely due to apoptosis.. In addition, we report that this non-thermal plasma torch kills melanoma cells growing in soft agar, suggesting that the plasma torch is capable of inducing melanoma cell death in 3D settings. We demonstrate that the presence of gap junctions may increase the area of cell death, likely due to the "bystander effect" of passing apoptotic signals between cells. Our findings provide a basis for further development of this non-invasive plasma torch as a potential treatment for melanoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895073      PMCID: PMC3493438          DOI: 10.4161/cbt.21787

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  26 in total

Review 1.  Radiation-induced bystander signalling in cancer therapy.

Authors:  Kevin M Prise; Joe M O'Sullivan
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

2.  Bystander effects in unicellular organisms.

Authors:  Linda C DeVeaux; Lynn S Durtschi; Jonathan G Case; Douglas P Wells
Journal:  Mutat Res       Date:  2006-01-18       Impact factor: 2.433

3.  Towards solid tumor treatment by nanosecond pulsed electric fields.

Authors:  Alex T Esser; Kyle C Smith; T R Gowrishankar; James C Weaver
Journal:  Technol Cancer Res Treat       Date:  2009-08

Review 4.  Gap junctions and connexins as therapeutic targets in cancer.

Authors:  Mustapha Kandouz; Gerald Batist
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

Review 5.  The sterile inflammatory response.

Authors:  Kenneth L Rock; Eicke Latz; Fernando Ontiveros; Hajime Kono
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 6.  The skin: an indispensable barrier.

Authors:  Ehrhardt Proksch; Johanna M Brandner; Jens-Michael Jensen
Journal:  Exp Dermatol       Date:  2008-12       Impact factor: 3.960

7.  Gallic acid ester derivatives induce apoptosis and cell adhesion inhibition in melanoma cells: The relationship between free radical generation, glutathione depletion and cell death.

Authors:  Claudriana Locatelli; Paulo C Leal; Rosendo A Yunes; Ricardo J Nunes; Tânia B Creczynski-Pasa
Journal:  Chem Biol Interact       Date:  2009-07-03       Impact factor: 5.192

8.  Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.

Authors:  Michael O Meyers; Jen Jen Yeh; Jill Frank; Patricia Long; Allison M Deal; Keith D Amos; David W Ollila
Journal:  Ann Surg Oncol       Date:  2008-12-20       Impact factor: 5.344

9.  Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species.

Authors:  Jérôme Alexandre; Yumin Hu; Weiqin Lu; Helene Pelicano; Peng Huang
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

Review 10.  Melanoma biology and new targeted therapy.

Authors:  Vanessa Gray-Schopfer; Claudia Wellbrock; Richard Marais
Journal:  Nature       Date:  2007-02-22       Impact factor: 49.962

View more
  32 in total

1.  Aqueous Plasma Pharmacy: Preparation Methods, Chemistry, and Therapeutic Applications.

Authors:  Jessica M Joslin; James R McCall; Justin P Bzdek; Derek C Johnson; Brooks M Hybertson
Journal:  Plasma Med       Date:  2016

2.  Evaluation of non-thermal plasma-induced anticancer effects on human colon cancer cells.

Authors:  Jae-Sun Choi; Jeongho Kim; Young-Jun Hong; Woom-Yee Bae; Eun Ha Choi; Joo-Won Jeong; Hun-Kuk Park
Journal:  Biomed Opt Express       Date:  2017-04-26       Impact factor: 3.732

3.  Theranostic Potential of Adaptive Cold Atmospheric Plasma with Temozolomide to Checkmate Glioblastoma: An In Vitro Study.

Authors:  Vikas Soni; Manish Adhikari; Li Lin; Jonathan H Sherman; Michael Keidar
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

4.  Adaptation of Operational Parameters of Cold Atmospheric Plasma for in Vitro Treatment of Cancer Cells.

Authors:  Eda Gjika; Sonali Pal-Ghosh; Anna Tang; Megan Kirschner; Gauri Tadvalkar; Jerome Canady; Mary Ann Stepp; Michael Keidar
Journal:  ACS Appl Mater Interfaces       Date:  2018-03-06       Impact factor: 9.229

5.  Effect of cold plasma on glial cell morphology studied by atomic force microscopy.

Authors:  Nina Recek; Xiaoqian Cheng; Michael Keidar; Uros Cvelbar; Alenka Vesel; Miran Mozetic; Jonathan Sherman
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

6.  Cold Atmospheric Pressure Plasma-Activated Medium Induces Selective Cell Death in Human Hepatocellular Carcinoma Cells Independently of Singlet Oxygen, Hydrogen Peroxide, Nitric Oxide and Nitrite/Nitrate.

Authors:  Yan Li; Tianyu Tang; Haejune Lee; Kiwon Song
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

7.  Combined Anticancer Effect of Plasma-Activated Infusion and Salinomycin by Targeting Autophagy and Mitochondrial Morphology.

Authors:  Takashi Ando; Manami Suzuki-Karasaki; Miki Suzuki-Karasaki; Jiro Ichikawa; Toyoko Ochiai; Yukihiro Yoshida; Hirotaka Haro; Yoshihiro Suzuki-Karasaki
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

8.  Restoration of sensitivity in chemo-resistant glioma cells by cold atmospheric plasma.

Authors:  Julia Köritzer; Veronika Boxhammer; Andrea Schäfer; Tetsuji Shimizu; Tobias G Klämpfl; Yang-Fang Li; Christian Welz; Sabina Schwenk-Zieger; Gregor E Morfill; Julia L Zimmermann; Jürgen Schlegel
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

9.  Non-thermal atmospheric pressure plasma inhibits thyroid papillary cancer cell invasion via cytoskeletal modulation, altered MMP-2/-9/uPA activity.

Authors:  Jae Won Chang; Sung Un Kang; Yoo Seob Shin; Kang Il Kim; Seong Jin Seo; Sang Sik Yang; Jong-Soo Lee; Eunpyo Moon; Keunho Lee; Chul-Ho Kim
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

10.  The effect of tuning cold plasma composition on glioblastoma cell viability.

Authors:  Xiaoqian Cheng; Jonathan Sherman; William Murphy; Edward Ratovitski; Jerome Canady; Michael Keidar
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.